- An overview of critical decision-points in the medical product lifecycle: Where to include patient preference information in the decision-making process
- Roadmap for patient involvement -- provides an overview of 15 decision-points with the potential to include PP information
- Improving Patient Involvement in Medicines Research and Development: A Practical Roadmap
- Patient-Focused Benefit-Risk Analysis to Inform Regulatory Decisions: The European Union Perspective
- EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes
- EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Ethical Review of Clinical Trials
- EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment
- Where patients can be involved in the process of medicines R&D. See Figure 1.
- Improving patient informed consent for haemophilia gene therapy: the case for change
- Patient-reported outcomes in the regulatory approval of medical devices